Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue... Show more
Cboe Global Markets is one of the world's leading exchange operators and financial market infrastructure providers. Headquartered in Chicago, the company runs derivatives, equities, and foreign exchange markets, serving institutional and retail investors globally. Cboe pioneered the first listed options exchange in 1973 and later created the VIX Index — the world's most widely followed gauge of market volatility. Its proprietary index options franchise, particularly S&P 500 Index (SPX) options and zero-days-to-expiration (0DTE) products, generates high-margin transaction revenue and underpins much of the company's earnings power. With a market capitalization of approximately $30 billion, Cboe competes alongside exchange peers such as CME, ICE, and NDAQ.
Over the last 30 days, CBOE shares climbed from $242.21 (close on June 26, 2026) to $285.07 (close on July 24, 2026), a gain of approximately 17.7%. This sharp rebound followed a period of intense selling pressure that had driven the stock to a multi-month low of $231.51 on June 29. The July recovery was broad-based, with seven of the last ten trading sessions in the period closing in positive territory and volume spiking notably on July 7–8 and July 22–23.
Looking at the full quarter, however, the stock is down roughly 4.5% from its April 27 close of $298.44. This quarterly decline reflects the dramatic selloff triggered by regulatory developments in late May and June, which erased gains from an earlier rally that had pushed CBOE to a 52-week high of approximately $371 in mid-May. The stock's path over the quarter illustrates a pronounced V-shaped pattern: a steep drop followed by a partial but significant recovery.
The 30-day rally was primarily driven by a combination of fundamental strength, bargain hunting, and easing regulatory fears. On July 8, Cboe announced record options trading volumes for June 2026 and the second quarter overall, including a single-day record of 33.4 million contracts on June 5. The company simultaneously issued updated revenue-per-contract and net revenue capture guidance, giving investors a clearer picture of how elevated trading activity translates into transaction revenue. The stock surged more than 5% in a single session on the news.
Additionally, the market began to digest the competitive threat posed by CFTC-approved Bitcoin perpetual futures more calmly. Analysts at Barclays and RBC Capital argued that institutional investors were unlikely to abandon traditional options and futures products, while CME Group CEO Terrence Duffy publicly questioned the structure of perpetual contracts. As the initial panic subsided, institutional buyers stepped in at depressed valuations, and TD Cowen raised its CBOE price target from $259 to $304 on July 20, reinforcing positive sentiment.
New product initiatives also contributed to the improved outlook. Cboe launched "Cboe Predicts," a prediction markets suite built around Mini S&P 500 Index binary options, and filed with the SEC to list binary options linked to corporate earnings for companies including AAPL, TSLA, and NVDA. The company also expanded its index options lineup with daily-expiring Dow Jones Industrial Average options.
Cboe's quarterly performance was defined by two opposing forces. In early May, the company reported Q1 2026 earnings of $3.70 per share — a 10.3% beat versus analyst estimates — alongside revenue of $728.9 million, up 29% year-over-year. The stock surged 8.95% the following day and continued climbing to an all-time high above $371 by May 19, supported by strong derivatives volumes and elevated market volatility.
The tide turned sharply on May 29, when the CFTC approved Kalshi to list Bitcoin perpetual futures on regulated exchanges. Investors feared that perpetual contracts — derivatives with no expiration date that dominate offshore crypto markets with over $90 trillion in annual volume — could eventually expand into equity index products, directly threatening Cboe's lucrative SPX options franchise. The ensuing selloff wiped out more than $100 billion in combined market value across CBOE, CME, ICE, and NDAQ. CBOE bore the brunt of the damage, falling approximately 37% from its May peak to the June 29 trough.
For traders seeking a data-driven edge amid volatile markets, Tickeron's Trending AI Robots page offers a curated selection of top-performing AI-powered trading bots. Tickeron hosts hundreds of AI robots that actively trade thousands of tickers across equities, ETFs, and cryptocurrencies, but only the most relevant and consistently high-performing strategies appear in this featured section. These bots span a variety of approaches — from short-term swing trading to longer-duration trend-following models — each with distinct performance metrics, risk profiles, and strategy parameters clearly displayed. Whether markets are trending sharply or consolidating, the Trending AI Robots page can help traders identify automated strategies aligned with current conditions.
The most immediate catalyst for CBOE is the Q2 2026 earnings report scheduled for July 31. Analysts expect EPS of approximately $3.41 on revenue of $708.5 million, representing year-over-year growth of 38.6% and 20.6%, respectively. Strong option volumes in June suggest the company may deliver another beat. Beyond earnings, investors should monitor any further CFTC guidance on whether perpetual futures will be permitted to expand into equity or commodity asset classes. Additional product-related catalysts include the rollout of Cboe Predicts across more retail brokers and potential SEC feedback on the binary options filing. Broader factors — including Federal Reserve policy, VIX levels, and retail trading activity — will also influence transaction-driven revenue in the quarters ahead. Cboe's heavy reliance on its S&P index options licensing agreement with S&P Dow Jones Indices remains a structural consideration for long-term investors.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CBOE broke above its upper Bollinger Band on July 31, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 45 similar instances where the stock broke above the upper band. In of the 45 cases the stock fell afterwards. This puts the odds of success at .
The 10-day RSI Indicator for CBOE moved out of overbought territory on August 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on August 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CBOE as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CBOE turned negative on August 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 56 similar instances when the indicator turned negative. In of the 56 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBOE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
CBOE moved above its 50-day moving average on July 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CBOE crossed bullishly above the 50-day moving average on July 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CBOE advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 270 cases where CBOE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CBOE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.441) is normal, around the industry mean (5.442). P/E Ratio (22.843) is within average values for comparable stocks, (25.936). Projected Growth (PEG Ratio) (2.490) is also within normal values, averaging (2.911). Dividend Yield (0.010) settles around the average of (0.018) among similar stocks. P/S Ratio (6.086) is also within normal values, averaging (8.001).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of a marketplace for trading equity and index options
Industry FinancialPublishingServices